Advertisement

Comparison of Outcomes and Mortality in Patients Having Left Ventricular Assist Device Implanted Early -vs- Late After Diagnosis of Cardiomyopathy

Published:February 03, 2021DOI:https://doi.org/10.1016/j.amjcard.2021.01.027
      LVAD implantation in patients with a recently diagnosed cardiomyopathy has been poorly investigated. This work aims at describing the characteristics and outcomes of patients receiving a LVAD within 30 days following the diagnosis of cardiomyopathy. Patients from the ASSIST-ICD study was divided into recently and remotely diagnosed cardiomyopathy based on the time from initial diagnosis of cardiomyopathy to LVAD implantation using the cut point of 30 days. The primary end point of the study was all-cause mortality at 30-day and during follow-up. A total of 652 patients were included and followed during a median time of 9.1 (2.5 to 22.1) months. In this population, 117 (17.9%) had a recently diagnosed cardiomyopathy and had LVAD implantation after a median time of 15.0 (9.0 to 24.0) days following the diagnosis. This group of patients was significantly younger, with more ischemic cardiomyopathy, more sudden cardiac arrest (SCA) events at the time of the diagnosis and were more likely to receive temporary mechanical support before LVAD compared with the remotely diagnosed group. Postoperative in-hospital survival was similar in groups, but recently diagnosed patients had a better long-term survival after hospital discharge. SCA before LVAD and any cardiac surgery combined with LVAD implantation were identified as 2 independent predictors of postoperative mortality in recently diagnosed patients. In conclusion, rescue LVAD implantation for recently diagnosed severe cardiomyopathy is common in clinical practice. Such patients experience a relatively low postoperative mortality and have a better long-term survival compared with remotely diagnosed patients.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kirkpatrick JN
        • Wieselthaler G
        • Strueber M
        • Sutton MGSJ
        • Rame JE.
        Ventricular assist devices for treatment of acute heart failure and chronic heart failure.
        Heart. 2015; 101: 1091-1096
        • Ponikowski P
        • Voors AA
        • Anker SD
        • Bueno H
        • Cleland JGF
        • Coats AJS
        • Falk V
        • González-Juanatey JR
        • Harjola V-P
        • Jankowska EA
        • Jessup M
        • Linde C
        • Nihoyannopoulos P
        • Parissis JT
        • Pieske B
        • Riley JP
        • Rosano GMC
        • Ruilope LM
        • Ruschitzka F
        • Rutten FH
        • van der Meer P
        • ESC Scientific Document Group
        2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure : The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC), Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
        Eur Heart J. 2016; 37: 2129-2200
        • Pawale A
        • Pinney S
        • Ashley K
        • Flynn R
        • Milla F
        • Anyanwu AC.
        Implantable left ventricular assist devices as initial therapy for refractory postmyocardial infarction cardiogenic shock.
        Eur J Cardiothorac Surg. 2013; 44: 213-216
        • Takayama H
        • Truby L
        • Koekort M
        • Uriel N
        • Colombo P
        • Mancini DM
        • Jorde UP
        • Naka Y.
        Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era.
        J Heart Lung Transplant. 2013; 32: 106-111
        • Pawale A
        • Schwartz Y
        • Itagaki S
        • Pinney S
        • Adams DH
        • Anyanwu AC.
        Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock.
        J Thorac Cardiovasc Surg. 2018; 155: 1059-1068
        • Galand V
        • Flécher E
        • Auffret V
        • Boulé S
        • Vincentelli A
        • Dambrin C
        • Mondoly P
        • Sacher F
        • Nubret K
        • Kindo M
        • Cardi T
        • Gaudard P
        • Rouvière P
        • Michel M
        • Gourraud JB
        • Defaye P
        • Chavanon O
        • Verdonk C
        • Ghodbane W
        • Pelcé E
        • Gariboldi V
        • Pozzi M
        • Obadia JF
        • Litzler PY
        • Anselme F
        • Babatasi G
        • Belin A
        • Garnier F
        • Bielefeld M
        • Hamon D
        • Radu C
        • Pierre B
        • Bourguignon T
        • Eschalier R
        • D'Ostrevy N
        • Bories MC
        • Marijon E
        • Vanhuyse F
        • Blangy H
        • Verhoye JP
        • Leclercq C
        • Martins RP
        • ASSIST-ICD Investigators
        Predictors and clinical impact of late ventricular arrhythmias in patients with continuous-flow left ventricular assist devices.
        JACC: Clinical Electrophysiology. 2018; 4: 1166-1175
        • Kurmani S
        • Squire I.
        Acute Heart Failure: Definition, Classification and Epidemiology.
        Curr Heart Fail Rep. 2017; 14: 385-392
        • Bahit MC
        • Kochar A
        • Granger CB.
        Post-myocardial infarction heart failure.
        J Am Coll Cardiol HF. 2018; 6: 179-186
        • Spinar J
        • Parenica J
        • Vitovec J
        • Widimsky P
        • Linhart A
        • Fedorco M
        • Malek F
        • Cihalik C
        • Spinarová L
        • Miklik R
        • Felsoci M
        • Bambuch M
        • Dusek L
        • Jarkovsky J
        Baseline characteristics and hospital mortality in the Acute Heart Failure Database (AHEAD) Main registry.
        Crit Care. 2011; 15: R291
        • Kirklin JK
        • Naftel DC
        • Kormos RL
        • Stevenson LW
        • Pagani FD
        • Miller MA
        • Baldwin JT
        • Young JB.
        Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients.
        J Heart Lung Transplantat. 2013; 32: 141-156
        • Kirklin JK
        • Pagani FD
        • Kormos RL
        • Stevenson LW
        • Blume ED
        • Myers SL
        • Miller MA
        • Baldwin JT
        • Young JB
        • Naftel DC.
        Eighth annual INTERMACS report: Special focus on framing the impact of adverse events.
        J. Heart Lung Transplant. 2017; 36: 1080-1086
        • Adesiyun TA
        • McLean RC
        • Tedford RJ
        • Whitman GJR
        • Sciortino CM
        • Conte JV
        • Shah AS
        • Russell SD.
        Long-term follow-up of continuous flow left ventricular assist devices: complications and predisposing risk factors.
        Int J Artif Organs. 2017; 40: 622-628
        • Wong CX
        • Brown A
        • Lau DH
        • Chugh SS
        • Albert CM
        • Kalman JM
        • Sanders P.
        Epidemiology of sudden cardiac death: Global and Regional Perspectives.
        Heart, Lung and Circulation. 2019; 28: 6-14
        • Mongardon N
        • Bouglé A
        • Geri G
        • Daviaud F
        • Morichau-Beauchant T
        • Tissier R
        • Dumas F
        • Cariou A.
        Pathophysiology and management of post-cardiac arrest syndrome.
        Annales Françaises d'Anesthésie et de Réanimation. 2013; 32: 779-786
        • Galand V
        • Flécher E
        • Auffret V
        • Pichard C
        • Boulé S
        • Vincentelli A
        • Rollin A
        • Mondoly P
        • Barandon L
        • Pernot M
        • Kindo M
        • Cardi T
        • Gaudard P
        • Rouvière P
        • Sénage T
        • Jacob N
        • Defaye P
        • Chavanon O
        • Verdonk C
        • Ghodbane W
        • Pelcé E
        • Gariboldi V
        • Pozzi M
        • Obadia JF
        • Savouré A
        • Anselme F
        • Babatasi G
        • Belin A
        • Garnier F
        • Bielefeld M
        • Hamon D
        • Lellouche N
        • Pierre B
        • Bourguignon T
        • Eschalier R
        • D'Ostrevy N
        • Bories MC
        • Marijon E
        • Vanhuyse F
        • Blangy H
        • Verhoye JP
        • Leclercq C
        • Martins RP
        Early ventricular arrhythmias after LVAD implantation is the strongest predictor of 30-day post-operative mortality.
        JACC: Clinical Electrophysiology. 2019; 5: 944-954
        • Salis S
        • Mazzanti VV
        • Merli G
        • Salvi L
        • Tedesco CC
        • Veglia F
        • Sisillo E.
        Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery.
        J. Cardiothorac. Vasc. Anesth. 2008; 22: 814-822
        • Akin S
        • Soliman O
        • de By TMMH
        • Muslem R
        • Tijssen JGP
        • Schoenrath F
        • Meyns B
        • Gummert JF
        • Mohacsi P
        • Caliskan K
        • investigators EUROMACS
        Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS).
        Intensive Care Med. 2020; 46: 1349-1360
        • Pal JD
        • Klodell CT
        • John R
        • Pagani FD
        • Rogers JG
        • Farrar DJ
        • Milano CA
        HeartMate II clinical investigators. Low operative mortality with implantation of a continuous-flow left ventricular assist device and impact of concurrent cardiac procedures.
        Circulation. 2009; 120: S215-S219